Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
318.13
-4.46 (-1.38%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Labcorp Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 14,348 | 13,952 | 13,009 | 12,162 | 11,864 | 13,136 | |
Revenue Growth | 6.41% | 7.25% | 6.97% | 2.51% | -9.69% | -6.03% |
Cost of Revenue | 10,204 | 9,939 | 9,385 | 8,797 | 8,155 | 8,144 |
Gross Profit | 4,144 | 4,013 | 3,624 | 3,365 | 3,709 | 4,992 |
Selling, General & Admin | 2,230 | 2,227 | 2,230 | 2,032 | 1,763 | 1,690 |
Amortization of Goodwill & Intangibles | 295.8 | 280 | 256.4 | 219.8 | 193.6 | 141.1 |
Operating Expenses | 2,526 | 2,507 | 2,486 | 2,252 | 1,957 | 1,831 |
Operating Income | 1,618 | 1,505 | 1,138 | 1,113 | 1,752 | 3,161 |
Interest Expense | -227.2 | -224.1 | -208.3 | -199.6 | -179.8 | -211.8 |
Interest & Investment Income | 24.8 | 15.2 | 22.3 | 28.8 | 7.5 | 8.8 |
Earnings From Equity Investments | -22.6 | -13.3 | -1.4 | -1.4 | 5.4 | 26.5 |
Other Non Operating Income (Expenses) | -9.7 | -1.3 | 65.2 | 26.4 | -32.2 | -46.3 |
EBT Excluding Unusual Items | 1,379 | 1,282 | 1,016 | 967 | 1,553 | 2,938 |
Merger & Restructuring Charges | -146.3 | -127.2 | -46 | -49.1 | -54 | -24 |
Impairment of Goodwill | - | - | - | -349 | - | - |
Gain (Loss) on Sale of Investments | -16.5 | -42.6 | -11.4 | - | - | 61.8 |
Gain (Loss) on Sale of Assets | - | - | 6.4 | - | - | - |
Asset Writedown | -4.3 | -4.3 | -5.3 | - | -261.7 | -88.4 |
Other Unusual Items | 21.9 | - | - | - | - | - |
Pretax Income | 1,234 | 1,108 | 959.5 | 568.9 | 1,237 | 2,888 |
Income Tax Expense | 230.2 | 229.8 | 212.4 | 188.5 | 233.9 | 690 |
Earnings From Continuing Operations | 1,004 | 877.7 | 747.1 | 380.4 | 1,004 | 2,198 |
Earnings From Discontinued Operations | - | - | - | 38.8 | 277.1 | 181.9 |
Net Income to Company | 1,004 | 877.7 | 747.1 | 419.2 | 1,281 | 2,380 |
Minority Interest in Earnings | -1.2 | -1.2 | -1.1 | -1.2 | -1.5 | -2.2 |
Net Income | 1,002 | 876.5 | 746 | 418 | 1,279 | 2,377 |
Net Income to Common | 1,002 | 876.5 | 746 | 418 | 1,279 | 2,377 |
Net Income Growth | 31.29% | 17.49% | 78.47% | -67.32% | -46.20% | 52.77% |
Shares Outstanding (Basic) | 82 | 83 | 84 | 87 | 91 | 97 |
Shares Outstanding (Diluted) | 83 | 84 | 84 | 88 | 92 | 98 |
Shares Change | -1.49% | -0.71% | -3.65% | -4.37% | -6.05% | -0.51% |
EPS (Basic) | 12.16 | 10.53 | 8.89 | 4.80 | 14.04 | 24.58 |
EPS (Diluted) | 12.08 | 10.46 | 8.84 | 4.77 | 13.97 | 24.39 |
EPS Growth | 33.20% | 18.33% | 85.21% | -65.82% | -42.73% | 53.56% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,155 | 1,206 | 1,096 | 874.1 | 1,417 | 2,597 |
Free Cash Flow Per Share | 13.93 | 14.39 | 12.98 | 9.98 | 15.47 | 26.63 |
Dividend Per Share | 2.880 | 2.880 | 2.880 | 2.880 | 2.160 | - |
Dividend Growth | 0% | 0% | 0% | 33.33% | - | - |
Gross Margin | 28.88% | 28.76% | 27.86% | 27.67% | 31.26% | 38.01% |
Operating Margin | 11.28% | 10.79% | 8.75% | 9.15% | 14.77% | 24.06% |
Profit Margin | 6.99% | 6.28% | 5.73% | 3.44% | 10.78% | 18.10% |
Free Cash Flow Margin | 8.05% | 8.64% | 8.42% | 7.19% | 11.95% | 19.77% |
EBITDA | 2,320 | 2,192 | 1,789 | 1,697 | 2,222 | 3,664 |
EBITDA Margin | 16.17% | 15.71% | 13.75% | 13.96% | 18.73% | 27.89% |
D&A For EBITDA | 701.8 | 686.6 | 651 | 584.4 | 469.5 | 503.3 |
EBIT | 1,618 | 1,505 | 1,138 | 1,113 | 1,752 | 3,161 |
EBIT Margin | 11.28% | 10.79% | 8.75% | 9.15% | 14.77% | 24.06% |
Effective Tax Rate | 18.66% | 20.75% | 22.14% | 33.13% | 18.90% | 23.89% |